Q1 2024 · 13F-HR
PERCEPTIVE ADVISORS LLCholdings as filed
Filed 2024-05-15 · accession 0001012975-24-000218
$5.76B
Reported value
112
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $456.3M | 7.92% | 10,794,876 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $330.5M | 5.74% | 28,057,456 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $285.6M | 4.96% | 19,272,991 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $273.6M | 4.75% | 3,933,556 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $209.0M | 3.63% | 2,783,454 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $179.4M | 3.12% | 2,699,345 | Common | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $148.8M | 2.58% | 4,256,104 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $145.5M | 2.53% | 6,825,395 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $141.6M | 2.46% | 3,268,579 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $132.0M | 2.29% | 1,932,759 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $131.6M | 2.29% | 3,074,542 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $124.6M | 2.16% | 1,429,563 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $114.8M | 1.99% | 429,953 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $111.4M | 1.93% | 2,262,462 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $110.9M | 1.93% | 804,409 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $97.0M | 1.68% | 2,556,679 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $95.7M | 1.66% | 2,963,212 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $94.3M | 1.64% | 1,725,047 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $92.0M | 1.60% | 6,906,646 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $91.2M | 1.58% | 6,485,420 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $88.2M | 1.53% | 1,105,341 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $81.5M | 1.42% | 994,098 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $80.6M | 1.40% | 5,753,798 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $79.4M | 1.38% | 12,757,562 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $77.0M | 1.34% | 3,448,004 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $73.0M | 1.27% | 1,055,355 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $69.3M | 1.20% | 757,225 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $69.1M | 1.20% | 1,476,203 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $68.7M | 1.19% | 11,331,103 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $68.1M | 1.18% | 525,683 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $64.0M | 1.11% | 3,657,099 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $60.5M | 1.05% | 3,761,576 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $58.5M | 1.02% | 939,866 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $57.3M | 0.99% | 1,304,105 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $56.5M | 0.98% | 2,668,978 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $54.4M | 0.95% | 8,005,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $51.0M | 0.89% | 1,236,603 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $51.0M | 0.89% | 2,362,279 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $50.1M | 0.87% | 821,589 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $48.5M | 0.84% | 1,801,068 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $48.2M | 0.84% | 4,582,409 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $47.1M | 0.82% | 1,296,416 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $43.7M | 0.76% | 1,412,033 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $42.5M | 0.74% | 6,433,369 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $42.3M | 0.73% | 2,319,646 | Common | SOLE |
| 92511W108 | — | VERRICA PHARMACEUTICALS INC | $42.0M | 0.73% | 7,099,182 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $40.6M | 0.71% | 101,800 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $38.4M | 0.67% | 892,208 | Common | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $37.0M | 0.64% | 12,594,211 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $35.0M | 0.61% | 1,387,471 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $34.8M | 0.61% | 3,083,307 | Common | SOLE |
| 515069201 | — | LANDOS BIOPHARMA INC | $31.9M | 0.55% | 1,486,991 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $30.3M | 0.53% | 3,324,468 | Common | SOLE |
| 89455T109 | TMCI | TREACE MED CONCEPTS INC | $30.1M | 0.52% | 2,304,954 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $29.3M | 0.51% | 1,716,660 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $28.8M | 0.50% | 994,323 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $28.4M | 0.49% | 245,205 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $28.1M | 0.49% | 8,593,586 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $27.6M | 0.48% | 4,330,745 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $21.5M | 0.37% | 3,007,858 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $20.7M | 0.36% | 1,410,438 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $19.9M | 0.35% | 618,885 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $19.4M | 0.34% | 106,500 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $18.7M | 0.32% | 300,000 | PUT | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $17.0M | 0.30% | 339,012 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $16.9M | 0.29% | 998,888 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $16.7M | 0.29% | 299,000 | Common | SOLE |
| 04746L104 | — | ATHIRA PHARMA INC | $14.8M | 0.26% | 5,402,964 | Common | SOLE |
| 87357P100 | TCMD | TACTILE SYS TECHNOLOGY INC | $14.7M | 0.25% | 903,085 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $13.4M | 0.23% | 2,545,881 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $12.5M | 0.22% | 1,553,929 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $12.2M | 0.21% | 589,646 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $11.3M | 0.20% | 1,074,807 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $11.0M | 0.19% | 1,223,472 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $11.0M | 0.19% | 669,159 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $10.4M | 0.18% | 210,659 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $10.1M | 0.18% | 288,221 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $8.9M | 0.15% | 867,319 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $7.4M | 0.13% | 750,000 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $7.4M | 0.13% | 415,000 | Common | SOLE |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $6.5M | 0.11% | 480,483 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $5.9M | 0.10% | 883,333 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $5.9M | 0.10% | 500,000 | Common | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $5.7M | 0.10% | 1,052,887 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $5.6M | 0.10% | 378,327 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.2M | 0.09% | 500,000 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $4.9M | 0.09% | 3,545,454 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $4.8M | 0.08% | 1,679,125 | CALL | SOLE |
| 78464A870 | XBI | SPDR SER TR | $4.7M | 0.08% | 50,000 | PUT | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $4.2M | 0.07% | 82,299 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $4.1M | 0.07% | 175,000 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $4.0M | 0.07% | 700,000 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $3.9M | 0.07% | 5,584,699 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $3.7M | 0.06% | 150,000 | Common | SOLE |
| 896438504 | TRIB | TRINITY BIOTECH PLC | $3.7M | 0.06% | 1,800,000 | Common | SOLE |
| 63009J107 | NBTX | NANOBIOTIX | $3.6M | 0.06% | 555,066 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $3.4M | 0.06% | 500,000 | CALL | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $3.4M | 0.06% | 623,315 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $3.3M | 0.06% | 700,000 | PUT | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $3.2M | 0.06% | 100,000 | CALL | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $3.0M | 0.05% | 600,000 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $2.9M | 0.05% | 100,000 | CALL | SOLE |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $2.3M | 0.04% | 3,265,359 | Common | SOLE |
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS IN | $1.1M | 0.02% | 2,126,893 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $1.0M | 0.02% | 48,200 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $852,000 | 0.01% | 300,000 | Common | SOLE |
| 91822J202 | LO9A | VBI VACCINES INC CDA | $757,026 | 0.01% | 1,261,710 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $624,634 | 0.01% | 116,754 | Common | SOLE |
| 14171W202 | — | CAREMAX INC | $591,139 | 0.01% | 122,643 | Common | SOLE |
| 76155X118 | RVMDW | REVOLUTION MEDICINES INC | $45,625 | 0.00% | 250,000 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $5,033 | 0.00% | 166,666 | Common | SOLE |
| 14171W111 | — | CAREMAX INC | $1,026 | 0.00% | 60,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.